Sepsis is a life threatening condition caused by the host immune system response for the infection caused by bacterial, viral, fungal, parasitic organisms. It occurs when the immune system get activated due to the invasion of the bacteria to respond to that infection and then there is a release of chemicals by the immune system to treat the infection. These chemicals enters in the blood stream and this causes inflammation in the body which causes clots and leakage in blood vessels which deprives the vital activity of the organs and other body parts. This disease is caused in 3 different stages which starts with sepsis, leading to severe sepsis, and finally septic shock, which is considered as a medical emergency. Due to the rise in hospital acquired infections and improved technology to for the treatment of sepsis will help in driving the growth of the market.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2110
The global market for sepsis diagnostics is expected to reach USD 710 million by the end of the forecasted period and is expected to grow at a CAGR of 8%.
On the basis of technology the market will be segmented into Molecular Diagnostics, Biomarkers, and Immunoassays among others. The molecular techniques can be applied directly on whole blood samples. They are the best choice for rapid identification of a microorganism in the blood. The main advantages of PCR detection directly from the blood are the increased sensitivity and the avoidance of time-consuming culture. This results in substantial reduction in turnaround time even compared with PCR identification from positive blood cultures.
Technological advances in the field of diagnostics along with increasing need for quick and accurate results. Moreover, inclination of doctors towards molecular diagnostic techniques for diagnosis are factors which will boost the growth of the Sepsis diagnostics market.
Key Players for Global Sepsis Diagnostics Market:
Some of the key players in this market are: bioMérieux, Inc. (US), EKF Diagnostics (UK), Immunexpress (US), T2 Biosystems, Inc. (US), Becton, Dickinson and Company (US), Axis-Shield Diagnostics Ltd. (Scotland), Cube Dx GmbH (Austria), Sandstone Diagnostics, Inc. (US) and others.
Global sepsis diagnostics market has been segmented on the basis of technology which comprises molecular diagnostics, biomarkers, immunoassays and others. On the basis of type of product product types; the market is segmented into kits, instruments, blood culture media and others. On the basis of end users the market is segmented into pathology laboratories, specialty clinics, hospitals, diagnostic centers and others.
Regional Analysis of Global Sepsis Diagnostics Market:
Globally North America is the largest market for medical tourism. The North American market for sepsis diagnostics is expected to reach USD 320 million by the end of the forecasted period.
Europe is the second largest market for sepsis diagnostics which is expected to grow at the CAGR of 6.8%. Asia Pacific is expected to be fastest growing region in sepsis diagnostics market.
Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @https://www.marketresearchfuture.com/reports/sepsis-diagnostics-market-2110
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar